FRAGMENT 176-191 INJECTOR PEN 3ML 10MG

Fragment 176–191: The Fat‑Metabolism Peptide Fragment for Targeted Body‑Composition Research

In the innovative realm of peptide science, Fragment 176–191 stands out as a synthetic 16‑amino‑acid segment derived from the C‑terminal region of human growth hormone (hGH). Specifically amino acids 176 through 191.
This fragment has been explored in research programs aiming to isolate adipose‑tissue (fat) signaling associated with growth hormone while minimizing the broader growth‑factor cascade typically linked to full‑length hGH.

Rather than acting as a “general” growth pathway stimulant, Fragment 176–191 is investigated for its ability to influence fat‑cell lipid handling, including:

• Stimulating lipolysis (mobilization of stored fatty acids)

• Reducing lipogenesis (signals associated with new fat storage)

• Supporting fatty‑acid utilization (shifting energy use toward stored lipids in certain experimental models)

Five Key Highlights

1) Targeted Adipose‑Tissue Signaling for Body‑Composition Investigation

Fragment 176–191 is frequently described as a fat‑focused research peptide because studies of peptides derived from this hGH region emphasize adipose metabolism rather than generalized anabolic signaling. In research models, this makes it useful for programs evaluating:

• changes in fat mass vs. lean mass

• visceral/abdominal adiposity dynamics

• adipocyte responsiveness under high‑fat diet or obesity‑prone conditions
  The overall goal in these study designs is to examine whether a peptide fragment can bias metabolic output toward fat mobilization without the full systemic effects associated with intact growth hormone.

2) Lipolysis Support and Reduced Fat‑Storage Signaling

Excess fat accumulation is closely tied to impaired metabolic flexibility. Fragment 176–191 is investigated for its potential to:

• increase mobilization of stored triglycerides (lipolysis)

• reduce re‑esterification / storage signaling

• promote fatty‑acid availability for oxidation pathways

3) Enhanced Lipid Handling in Metabolic‑Stress Models

For teams studying metabolic resilience, Fragment 176–191 is commonly positioned in protocols looking at:

• diet‑induced weight gain trajectories

• triglyceride and lipid‑panel movement (study‑dependent)

• adipose gene expression associated with lipid uptake vs. breakdown

4) A Focus on Fat‑Pathway Selectivity vs. Broad Hormonal Output

A major reason Fragment 176–191 continues to draw attention is its positioning as a selective research tool: it is explored for metabolic actions associated with fat tissue while being studied for reduced involvement in growth‑factor signalingcompared with full‑length hGH.

In short, many research programs evaluate whether this fragment (and closely related peptides derived from the same region) can influence adipose metabolism without intentionally driving the classic growth‑hormone outcomes that are not the goal of body‑composition studies.

5) Practicality for Standardized Delivery and Repeatable Protocol Design

Because peptide research often requires tight control over administration variables, having a consistent delivery format is critical for reproducibility. Our Fragment 176–191 Peptide Injector is designed to support:

• measured, repeatable dispensing

• reduced handling variability compared to multi‑step mixing workflows

• streamlined integration into structured research protocols

This format is built for precision supporting clean study design where consistency matters.

Our Fragment 176–191 Peptide Injector

Our Fragment 176–191 Peptide Injector provides a convenient 3 mL formulation containing 10 mg of peptide, designed to support accurate dispensing in peptide research workflows. It is manufactured to high purity standards and intended for investigators prioritizing controlled administration variables, consistent formatting, and dependable lab handling.

Scientific Studies:

The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice

Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism

Pharmacotherapy: Current Perspectives and Future Directions 

Disclaimer: The summaries above describe findings from published scientific studies and are provided for educational and research‑discussion purposes only. They are not intended to diagnose, treat, cure, or prevent any disease, and they are not a substitute for medical advice. Therefore this product is not intended to be for human consumption!